Detalhe da pesquisa
1.
Variability in the Responses of Hepatitis B Virus D-Subgenotypes to Antiviral Therapy: Designing Pan-D-Subgenotypic Reverse Transcriptase Inhibitors.
J Virol
; 96(2): e0180021, 2022 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34730399
2.
A Model of Care Optimized for Marginalized Remote Population Unravels Migration Pattern in India.
Hepatology
; 73(4): 1261-1274, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32659859
3.
Hepatitis B virus suppresses complement C9 synthesis by limiting the availability of transcription factor USF-1 and inhibits formation of membrane attack complex: implications in disease pathogenesis.
J Biomed Sci
; 29(1): 97, 2022 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376872
4.
CD8+CD28- T cells: key cytotoxic players impacting disease pathogenesis in chronic HBV infection.
Clin Sci (Lond)
; 133(17): 1917-1934, 2019 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31477625
5.
Multifaceted Defects in Monocytes in Different Phases of Chronic Hepatitis B Virus Infection: Lack of Restoration after Antiviral Therapy.
Microbiol Spectr
; 10(6): e0193922, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36445121
6.
Distinctiveness in virological features and pathogenic potentials of subgenotypes D1, D2, D3 and D5 of Hepatitis B virus.
Sci Rep
; 8(1): 8055, 2018 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29795338